Evidence map›Paper›PMID 28680065›Full record

ArticleScientific reports2017

Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet.

Mónica Sánchez-Tapia, Miriam Aguilar-López, Claudia Pérez-Cruz, Edgar Pichardo-Ontiveros, Mei Wang, Sharon M Donovan, Armando R Tovar, Nimbe Torres

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03421301 nacompletednot on this map

A Dietary Intervention With Functional Foods Reduce Metabolic Endotoxemia and Attenuates Biochemical Abnormalities in Subjects With Type 2 Diabetes by Modifying the Gut Microbiota.

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2014 to 2016Enrolled81ConditionsType 2 Diabetes MellitusArmsdietary portfolio
NCT03611140 nacompletednot on this map

Effect of a Dietary Portfolio (PD) (Nopal, Chia, Soy, Oat and Inulin) and Physical Activity on Gut Microbiota in Patients With Metabolic Syndrome

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2014 to 2018Enrolled72ConditionsMetabolic SyndromeArmsDP, Placebo
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Sequential Fractionation ofFoods (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Evaluation of 3',4'-Di-Biomolecules · 2026
    Article
  6. Review
  7. Differential Effects ofNutrients · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Preventive Effects of anNutrients · 2025
    Article
  13. Oral Administration of anFoods (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Selected Mesoamerican Crops - Anti-Obesity Potential and Health Promotion. A Review.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Usefulness ofNutrients · 2024
    Review
  20. The Effect ofFoods (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mónica Sánchez-TapiaDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No 15, Ciudad de Mexico, 14080, Mexico City, Mexico.
Miriam Aguilar-LópezDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No 15, Ciudad de Mexico, 14080, Mexico City, Mexico.
Claudia Pérez-CruzDepartamento de Farmacología, Laboratorio de Neuroplasticidad y Neurodegeneración, CINVESTAV, Ciudad de Mexico, 07360, Mexico City, Mexico.
Edgar Pichardo-OntiverosDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No 15, Ciudad de Mexico, 14080, Mexico City, Mexico.
Mei WangDepartment of Food Science and Human Nutrition, University of Illinois, Illinois, IL, 61801, USA.
Sharon M DonovanDepartment of Food Science and Human Nutrition, University of Illinois, Illinois, IL, 61801, USA.
Armando R TovarDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No 15, Ciudad de Mexico, 14080, Mexico City, Mexico.
Nimbe TorresDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No 15, Ciudad de Mexico, 14080, Mexico City, Mexico. nimbester@gmail.com.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversity of Illinois Urbana-Champaign · USCenter for Research and Advanced Studies of the National Polytechnic Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current efforts are directed to reducing the gut dysbiosis and inflammation produced by obesity. The purpose of this study was to investigate whether consuming nopal, a vegetable rich in dietary fibre, vitamin C, and polyphenols can reduce the metabolic consequences of obesity by modifying the gut microbiota and preventing metabolic endotoxemia in rats fed a high fat and sucrose diet. With this aim, rats were fed a high fat diet with 5% sucrose in the drinking water (HFS) for 7 months and then were fed for 1 month with HFS + 5% nopal (HFS + N). The composition of gut microbiota was assessed by sequencing the 16S rRNA gene. Nopal modified gut microbiota and increased intestinal occludin-1 in the HFS + N group. This was associated with a decrease in metabolic endotoxemia, glucose insulinotropic peptide, glucose intolerance, lipogenesis, and metabolic inflexibility. These changes were accompanied by reduced hepatic steatosis and oxidative stress in adipose tissue and brain, and improved cognitive function, associated with an increase in B. fragilis. This study supports the use of nopal as a functional food and prebiotic for its ability to modify gut microbiota and to reduce metabolic endotoxemia and other obesity-related biochemical abnormalities.

Indexed as

AnimalsBacteriaDiet, High-FatDNA, BacterialDNA, RibosomalEndotoxemiaGastrointestinal MicrobiomeInsulin Receptor Substrate ProteinsLiverMaleObesityOpuntiaPlant PreparationsProto-Oncogene Proteins c-aktRatsRNA, Ribosomal, 16SDNA, BacterialDNA, RibosomalInsulin Receptor Substrate ProteinsIrs1 protein, ratPlant PreparationsProto-Oncogene Proteins c-aktRNA, Ribosomal, 16SSucrose

Identifiers

PMID28680065
PMCPMC5498631
OpenAlexW2732099757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.